查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908261

計算病理學市場規模、佔有率和趨勢分析報告：按組件、應用、技術、最終用途、地區和細分市場預測（2026-2033 年）

Computational Pathology Market Size, Share & Trends Analysis Report By Component, By Application, By Technology, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

計算病理學市場概覽

2025年全球計算病理學市場規模估計為7.2868億美元，預計到2033年將達到14.4762億美元。

預計從 2026 年到 2033 年，該行業將以 9.21% 的複合年成長率成長。這一成長歸因於醫療保健領域的投資不斷增加，這得益於機器學習和人工智慧 (AI) 技術的日益融合、對快速診斷先進解決方案的需求不斷成長、慢性病患病率不斷上升，以及專注於開發先進解決方案的市場參與企業。

癌症等慢性疾病的日益普及是推動市場發展的主要因素。癌症的高發生率要求病理學家掌握病理數據，以便為每位患者制定個人化治療方法。這導致病理學家越來越傾向於採用數位病理學，因為數位病理學可以提高診斷速度和準確性，並提供治療建議，從而改善患者預後。例如，根據2023年8月發表在《病理學雜誌》（Journal of Pathology）上的一項研究，用於分析和解讀組織病理學影像的深度學習和人工智慧（AI）演算法有望顯著提高診斷準確性和效率，尤其是在癌症診斷和預後方面。

將機器學習和人工智慧技術融入病理工作流程將顯著改變診斷過程。例如，Proscia 於 2024 年 10 月發布了一款數位病理工具包，旨在支援人工智慧模型的開發。這些工具使生命科學研究人員能夠將切片檢查切片影像轉化為定量數據，用於訓練底層模型、促進生物標記的發現並改善診斷。此類解決方案的開發能夠實現影像的快速準確分析，使病理學家能夠識別可能預示疾病進展的模式。透過自動化常規任務，人工智慧使病理學家能夠專注於更複雜的診斷挑戰，從而提高效率和準確性。這項變革將提升診斷準確性，並透過預測建模推動個人化醫療的發展。

市場蘊藏著巨大的機遇，而這主要得益於以下關鍵因素：人工智慧 (AI)、機器學習 (ML) 和數位影像技術的進步正在變革病理學工作流程，使組織切片的分析更加快速精準，並為疾病的診斷和預後提供關鍵資訊。隨著癌症和心血管疾病等慢性疾病在全球範圍內的日益流行，人們對快速準確診斷的需求也與日俱增，而這項技術進步正滿足了這一需求。

此外，遠距病理學的日益普及正在改善醫療服務的可近性，使偏遠地區的專家能夠獲得諮詢，尤其是在醫療資源有限的地區。數位醫療系統的整合提高了檢查室效率，實現了日常工作的自動化，使病理學家能夠專注於複雜的診斷，從而提高了診斷的準確性，並促進了個人化醫療的發展。此外，醫療服務提供者和產業相關人員對人工智慧驅動的病理診斷解決方案的研發投入不斷增加，也刺激了創新和市場成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 計算病理學市場變數、趨勢和範圍

  • 市場動態
  • 使用案例研究結果
  • 計算病理學市場分析工具
    • 產業分析—波特五力分析
    • PESTEL 分析
    • 科技趨勢分析

第4章 計算病理學市場：按組件分類的估算和趨勢分析

  • 按組件分類的市場佔有率（2025 年和 2033 年）
  • 全球計算病理學市場：組成部分展望
  • 軟體
  • 服務

第5章 計算病理學市場：按應用、估算和趨勢分析

  • 按應用領域分類的市場佔有率（2025 年和 2033 年）
  • 全球計算病理學市場：按應用領域分類的展望
  • 疾病診斷
  • 藥物發現與開發
  • 學術研究

第6章 計算病理學市場：依技術分類的估算與趨勢分析

  • 按技術分類的市場佔有率（2025 年和 2033 年）
  • 全球計算病理學市場：技術展望
  • 機器學習（ML）
    • 深度學習
    • 和老師
    • 無人監管
    • 其他
  • 自然語言處理（NLP）模型
  • 電腦視覺
  • 其他

第7章 計算病理學市場：依最終用途分類的估算與趨勢分析

  • 按最終用途分類的市場佔有率（2025 年和 2033 年）
  • 全球計算病理學市場：終端用戶展望
  • 醫院和診斷實驗室
  • 生物技術和製藥公司
  • 學術和研究機構
  • 其他

第8章 計算病理學市場按地區、估算和趨勢分析、組成部分、應用、技術和最終用途分類

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 全球市場概覽（按地區分類）
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 主要企業市佔率和地位分析（2025 年）
  • 公司簡介
    • 徠卡生物系統努斯洛赫有限公司（丹納赫子公司）
    • Hamamatsu Photonics KK
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Aiforia/Aiforia Technologies PLC
    • Epredia（3DHISTECH Ltd.）
    • Visiopharm A/S
    • Proscia Inc.
    • Mindpeak GmbH
    • Akoya Biosciences, Inc.（Quanterix 的子公司）
    • Paige AI, Inc.
    • CellaVision
    • aetherAI
    • Qritive
    • IBEX（IBEX MEDICAL ANALYTICS）
    • Nucleai, Inc.
Product Code: GVR-4-68040-548-5

Computational Pathology Market Summary

The global computational pathology market size was estimated at USD 728.68 million in 2025 and is projected to reach USD 1,447.62 million by 2033, growing at a CAGR of 9.21% from 2026 to 2033. The growth is attributed to the rising integration of machine learning and artificial intelligence (AI) technologies, the increasing demand for advanced solutions for faster diagnosis, the rising prevalence of chronic diseases, and increasing investment in healthcare, supported by market players focused on developing advanced solutions.

The growing prevalence of chronic diseases, such as cancer, predominantly drives the market. Owing to the high prevalence of cancer, pathologists require pathology data that can facilitate customizing therapies for patients. Thereby, digital pathology is increasingly being preferred by pathologists, as it accelerates the rate of diagnosis, increases diagnostic accuracy, and provides therapeutic recommendations to improve patient outcomes. For instance, according to a study published in the Journal of Pathology in August 2023, deep learning and artificial intelligence (AI) algorithms to analyze and interpret histopathology images promise substantial improvements in diagnostic accuracy and efficiency, especially for cancer diagnosis and prognosis.

The incorporation of machine learning and AI technologies into pathology workflows significantly transforms the diagnostic process. For instance, in October 2024, Proscia introduced digital pathology toolkits designed to facilitate the development of AI models. These tools enable life science researchers to convert biopsy slide images into quantitative data for training foundation models, improving biomarker discovery, and diagnostics. The development of such solutions enables the rapid and accurate analysis of images, allowing pathologists to identify patterns that may indicate disease progression. By automating routine tasks, AI enables pathologists to focus on more complex diagnostic challenges, thereby improving efficiency and accuracy. This shift enhances diagnostic precision and supports the development of personalized medicine through predictive modeling.

The market holds substantial opportunities driven by significant factors. Advances in artificial intelligence (AI), machine learning (ML), and digital imaging are transforming pathological workflows, enabling faster, more precise analysis of tissue slides and providing critical insights into disease diagnosis and prognosis. This technological progress is addressing the growing demand for rapid, accurate diagnostics, owing to the rising global prevalence of chronic diseases such as cancer and cardiovascular conditions.

Moreover, increasing adoption of telepathology is expanding remote expert consultations and improving healthcare access, especially in underserved regions. Integrating digital health systems enhances laboratory efficiency, automates routine tasks, and allows pathologists to focus on complex diagnostics, fostering greater accuracy and personalized medicine development. Furthermore, rising investments by healthcare providers and industry players in developing AI-powered pathology solutions stimulate innovation and market growth.

Global Computational Pathology Market Report Segmentation

This report forecasts revenue growth and provides, at global, regional, and country levels, an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global computational pathology market report based on components, application, technology, end-use, and region:

  • Component Outlook (Revenue, USD Million, 2021 - 2033)
  • Software
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Disease Diagnosis
  • Drug Discovery & Development
  • Academic Research
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Machine Learning (ML)
    • Deep Learning
    • Supervised
    • Unsupervised
    • Others
  • Natural Language Processing (NLP) Models
  • Computer Vision
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Regional scope
    • 1.1.2. Component
    • 1.1.3. Technology
    • 1.1.4. Application
    • 1.1.5. End Use
  • 1.2. Estimates and forecast timeline.
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database.
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Component
    • 2.2.2. Technology
    • 2.2.3. Application
    • 2.2.4. End Use
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Computational Pathology Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
      • 3.1.1.1. Increasing prevalence of chronic diseases
      • 3.1.1.2. Higher cost-efficiency
      • 3.1.1.3. Rapid technological advancements in computational pathology
      • 3.1.1.4. Emergence of Quantitative Continuous Scoring (QCS) in digital pathology
    • 3.1.2. Market restraint analysis
      • 3.1.2.1. High cost of implementing digital and computational pathology solutions
      • 3.1.2.2. Stringent regulatory requirements
    • 3.1.3. Market Opportunity Analysis
    • 3.1.4. Market Challenge Analysis
  • 3.2. Case Study Insights
  • 3.3. Computational Pathology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape
    • 3.3.3. Technology Trends Analysis

Chapter 4. Computational Pathology Market: Component Estimates & Trend Analysis

  • 4.1. Component Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Computational Pathology Market by Component Outlook
  • 4.4. Software
    • 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Computational Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Application Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Computational Pathology Market by Application Outlook
  • 5.4. Disease Diagnosis
    • 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Drug Discovery & Development
    • 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Academic Research
    • 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Computational Pathology Market: Technology Estimates & Trend Analysis

  • 6.1. Technology Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Computational Pathology Market by Technology Outlook
  • 6.4. Machine Learning (ML)
    • 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. Deep Learning
      • 6.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Supervised
      • 6.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Unsupervised
      • 6.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Others
      • 6.4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Natural Language Processing (NLP) Models
    • 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Computer Vision
    • 6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Computational Pathology Market: End Use Estimates & Trend Analysis

  • 7.1. End Use Market Share, 2025 & 2033
  • 7.2. Segment Dashboard
  • 7.3. Global Computational Pathology Market by End Use Outlook
  • 7.4. Hospitals and Diagnostic Labs
    • 7.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.5. Biotechnology and Pharmaceutical Companies
    • 7.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.6. Academic and Research Institutes
    • 7.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Computational Pathology Market: Regional Estimates & Trend Analysis, By Component, By Application, By Technology, By End Use

  • 8.1. Regional Market Share Analysis, 2025 & 2033
  • 8.2. Regional Market Dashboard
  • 8.3. Global Regional Market Snapshot
  • 8.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 8.5. North America
    • 8.5.1. U.S.
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. Canada
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Europe
    • 8.6.1. UK
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Germany
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. France
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Regulatory framework
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. Italy
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. Regulatory framework
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. Spain
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Regulatory framework
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Norway
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. Regulatory framework
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Sweden
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Regulatory framework
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.8. Denmark
      • 8.6.8.1. Key country dynamics
      • 8.6.8.2. Regulatory framework
      • 8.6.8.3. Competitive scenario
      • 8.6.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Asia Pacific
    • 8.7.1. Japan
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. China
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. India
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. Australia
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. South Korea
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Regulatory framework
      • 8.7.5.3. Competitive scenario
      • 8.7.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.6. Thailand
      • 8.7.6.1. Key country dynamics
      • 8.7.6.2. Regulatory framework
      • 8.7.6.3. Competitive scenario
      • 8.7.6.4. Singapore market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.8. Latin America
    • 8.8.1. Brazil
      • 8.8.1.1. Key country dynamics
      • 8.8.1.2. Regulatory framework
      • 8.8.1.3. Competitive scenario
      • 8.8.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. Argentina
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. Regulatory framework
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.9. MEA
    • 8.9.1. South Africa
      • 8.9.1.1. Key country dynamics
      • 8.9.1.2. Regulatory framework
      • 8.9.1.3. Competitive scenario
      • 8.9.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.9.2. Saudi Arabia
      • 8.9.2.1. Key country dynamics
      • 8.9.2.2. Regulatory framework
      • 8.9.2.3. Competitive scenario
      • 8.9.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.9.3. UAE
      • 8.9.3.1. Key country dynamics
      • 8.9.3.2. Regulatory framework
      • 8.9.3.3. Competitive scenario
      • 8.9.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.9.4. Kuwait
      • 8.9.4.1. Key country dynamics
      • 8.9.4.2. Regulatory framework
      • 8.9.4.3. Competitive scenario
      • 8.9.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
  • 9.3. Key company market share/position analysis, 2025
  • 9.4. Company Profiles
    • 9.4.1. Leica Biosystems Nussloch GmbH (subsidiary of Danaher)
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Hamamatsu Photonics K.K.
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Koninklijke Philips N.V.
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Olympus Corporation
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. F. Hoffmann-La Roche Ltd.
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Aiforia/ Aiforia Technologies PLC
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Epredia (3DHISTECH Ltd.)
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Visiopharm A/S
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. Proscia Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Mindpeak GmbH
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. Akoya Biosciences, Inc. (a Quanterix company)
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Paige AI, Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. CellaVision
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. aetherAI
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Qritive
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives
    • 9.4.16. IBEX (IBEX MEDICAL ANALYTICS)
      • 9.4.16.1. Company overview
      • 9.4.16.2. Financial performance
      • 9.4.16.3. Product benchmarking
      • 9.4.16.4. Strategic initiatives
    • 9.4.17. Nucleai, Inc.
      • 9.4.17.1. Company overview
      • 9.4.17.2. Financial performance
      • 9.4.17.3. Product benchmarking
      • 9.4.17.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America Computational Pathology Market, by Region, 2021 - 2033 (USD Million)
  • Table 3 North America Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 4 North America Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 5 North America Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 6 North America Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 7 U.S. Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 8 U.S. Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 9 U.S. Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 10 U.S. Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 11 Canada Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 12 Canada Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 13 Canada Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 14 Canada Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 15 Mexico Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 16 Mexico Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 17 Mexico Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Computational Pathology Market, by Region, 2021 - 2033 (USD Million)
  • Table 20 Europe Computational Pathology Market, by Component, 2021 - 2033 (USD Million)
  • Table 21 Europe Computational Pathology Market, by Technology, 2021 - 2033 (USD Million)
  • Table 22 Europe Computational Pathology Market, by Application, 2021 - 2033 (USD Million)
  • Table 23 Europe Computational Pathology Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24 Germany Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 25 Germany Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 26 Germany Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 27 Germany Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 28 UK Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 29 UK Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 30 UK Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 31 UK Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 32 France Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 33 France Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 34 France Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 35 France Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 36 Italy Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 37 Italy Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 38 Italy Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 39 Italy Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 40 Spain Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 41 Spain Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 42 Spain Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 43 Spain Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 44 Denmark Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 45 Denmark Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 46 Denmark Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 47 Denmark Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 48 Sweden Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 49 Sweden Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 50 Sweden Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 51 Sweden Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 52 Norway Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 53 Norway Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 54 Norway Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 55 Norway Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific Computational Pathology Market, by region, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 61 China Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 62 China Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 63 China Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 64 China Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 65 Japan Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 66 Japan Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 67 Japan Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 68 Japan Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 69 India Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 70 India Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 71 India Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 72 India Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 73 South Korea Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 74 South Korea Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 75 South Korea Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 76 South Korea Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 77 Australia Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 78 Australia Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 79 Australia Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 80 Australia Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 81 Thailand Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 82 Thailand Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 83 Thailand Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 84 Thailand Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 85 Latin America Computational Pathology Market, by region, 2021 - 2033 (USD Million)
  • Table 86 Latin America Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 87 Latin America Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 88 Latin America Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 89 Latin America Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 90 Brazil Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 91 Brazil Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 92 Brazil Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 93 Brazil Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 94 Argentina Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 95 Argentina Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 96 Argentina Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 97 Argentina Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 98 MEA Computational Pathology Market, by region, 2021 - 2033 (USD Million)
  • Table 99 MEA Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 100 MEA Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 101 MEA Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 102 MEA Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 103 South Africa Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 104 South Africa Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 105 South Africa Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 106 South Africa Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 110 Saudi Arabia Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 111 UAE Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 112 UAE Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 113 UAE Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 114 UAE Computational Pathology Market by End Use, 2021 - 2033 (USD Million)
  • Table 115 Kuwait Computational Pathology Market, 2021 - 2033 (USD Million)
  • Table 116 Kuwait Computational Pathology Market by Component, 2021 - 2033 (USD Million)
  • Table 117 Kuwait Computational Pathology Market by Technology, 2021 - 2033 (USD Million)
  • Table 118 Kuwait Computational Pathology Market by Application, 2021 - 2033 (USD Million)
  • Table 119 Kuwait Computational Pathology Market by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Computational Pathology Market outlook
  • Fig. 9 Computational Pathology competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Computational Pathology Market driver impact
  • Fig. 15 Computational Pathology Market restraint impact
  • Fig. 16 Computational Pathology Market strategic initiatives analysis
  • Fig. 17 Computational Pathology Market: Component movement analysis
  • Fig. 18 Computational Pathology Market: Component outlook and key takeaways
  • Fig. 19 Software market estimates and forecast, 2021 - 2033
  • Fig. 20 Services market estimates and forecast, 2021 - 2033
  • Fig. 21 Computational Pathology Market: Application movement analysis
  • Fig. 22 Computational Pathology Market: Application outlook and key takeaways
  • Fig. 23 Disease diagnosis market estimates and forecast, 2021 - 2033
  • Fig. 24 Drug discovery & development market estimates and forecast, 2021 - 2033
  • Fig. 25 Academic research market estimates and forecast, 2021 - 2033
  • Fig. 26 Computational Pathology Market: Technology movement analysis
  • Fig. 27 Computational Pathology Market: Technology outlook and key takeaways
  • Fig. 28 Machine Learning (ML) market estimates and forecast, 2021 - 2033
  • Fig. 29 Deep Learning market estimates and forecast, 2021 - 2033
  • Fig. 30 Supervised market estimates and forecast, 2021 - 2033
  • Fig. 31 Unsupervised market estimates and forecast, 2021 - 2033
  • Fig. 32 Others market estimates and forecast, 2021 - 2033
  • Fig. 33 Natural Language Processing (NLP) models market estimates and forecast, 2021 - 2033
  • Fig. 34 Computer vision market estimates and forecast, 2021 - 2033
  • Fig. 35 Others market estimates and forecast, 2021 - 2033
  • Fig. 36 Computational Pathology Market: End use movement analysis
  • Fig. 37 Computational Pathology Market: End use outlook and key takeaways
  • Fig. 38 Hospitals and Diagnostic Labs market estimates and forecast, 2021 - 2033
  • Fig. 39 Biotechnology and Pharmaceutical Companies market estimates and forecast, 2021 - 2033
  • Fig. 40 Academic and Research Institutes market estimates and forecast, 2021 - 2033
  • Fig. 41 Other market estimates and forecast, 2021 - 2033
  • Fig. 42 Global Computational Pathology Market: Regional movement analysis
  • Fig. 43 Global Computational Pathology Market: Regional outlook and key takeaways
  • Fig. 44 Global Computational Pathology Market share and leading players
  • Fig. 45 North America market share and leading players
  • Fig. 46 Europe market share and leading players
  • Fig. 47 Asia Pacific market share and leading players
  • Fig. 48 Latin America market share and leading players
  • Fig. 49 Middle East & Africa market share and leading players
  • Fig. 50 North America market estimates and forecasts, 2021 - 2033
  • Fig. 51 US market estimates and forecasts, 2021 - 2033
  • Fig. 52 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 53 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 54 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 55 UK market estimates and forecasts, 2021 - 2033
  • Fig. 56 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 57 France market estimates and forecasts, 2021 - 2033
  • Fig. 58 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 59 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 60 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 61 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 62 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 63 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 64 China market estimates and forecasts, 2021 - 2033
  • Fig. 65 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 66 India market estimates and forecasts, 2021 - 2033
  • Fig. 67 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 68 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 69 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 70 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 71 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 72 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 73 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 74 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 75 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 76 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 77 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 78 Market share of key market players- Computational Pathology Market
  • Fig. 79 Key Company Categorization
  • Fig. 80 Company Market Share/Position Analysis, 2025
  • Fig. 81 Strategic Framework